Fused heterocyclic compounds as ion channel modulators
摘要
The present invention relates to sodium channel inhibitors of Formula I: in which R1, R2, R3, R4, R5, R6, and R7 are as defined above, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes.
申请公布号
US8664379(B2)
申请公布日期
2014.03.04
申请号
US201213706786
申请日期
2012.12.06
申请人
GILEAD SCIENCES, INC.
发明人
ABELMAN MATTHEW;CHU NANCY;JIANG ROBERT H.;LEUNG KWAN;ZABLOCKI JEFF
